No abstract listed.
Associated Clinical Trials
Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses
Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome
Superiority of enviomycin or streptomycin over ethambutol in initial treatment of lung disease caused by Mycobacterium avium complex
Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex
Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs
Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness
Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease
Genetic characterization of Mycobacterium avium isolates recovered from humans and animals in Australia
Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus
Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis
Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease
Distribution of serotypes, IS901 and a 40 kDa protein in Mycobacterium avium complex strains isolated from man and animals in Denmark
Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease
Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.
Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species.
Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients
Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study
Successive follow-up of chest computed tomography in patients with Mycobacterium avium-intracellulare complex
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex
Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease
A comparative study on the different staining methods and number of specimens for the detection of acid fast bacilli
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
The significance of bronchoscopy for the diagnosis of Mycobacterium avium complex (MAC) pulmonary disease
Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease
Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification.
SURGICAL TREATMENT OF ATYPICAL MYCOBACTERIAL DISEASE; A SURVEY OF EXPERIENCE IN VETERANS ADMINISTRATION HOSPITALS
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study
Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection
Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients
Measurement of immunoglobulin G against Mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus
Use of glycopeptidolipid core antigen for serodiagnosis of mycobacterium avium complex pulmonary disease in immunocompetent patients
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy
Comparison of NaOH-N-acetyl cysteine and sulfuric acid decontamination methods for recovery of mycobacteria from clinical specimens
Use of the INNO-LiPA-MYCOBACTERIA assay (version 2) for identification of Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex isolates
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry
Evaluation of the GenoType Mycobacteria Direct assay for detection of Mycobacterium tuberculosis complex and four atypical mycobacterial species in clinical samples
The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study
Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series
Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease
Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease
Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition)
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study
Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings
Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection
Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome
Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study
Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group
Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients
Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics
Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems
Different morbidity after pneumonectomy: multidrug-resistant tuberculosis versus non-tuberculous mycobacterial infection
Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006
Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds
Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis
Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease
Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease
Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease
Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry
Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?
Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality
Rate of recovery of Mycobacterium tuberculosis from frozen acid-fast-bacillus smear-positive sputum samples subjected to long-term storage in Northwest Ethiopia
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Bronchoscopic microsampling for bacterial colony counting in relevant lesions in patients with pulmonary Mycobacterium avium complex infection
Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice
Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns
Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy
MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center
Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study
Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease
Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment
High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance
Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease
Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London
Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens
First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection
Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense
Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study
Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Severe vitamin D deficiency is associated with non-tuberculous mycobacterial lung disease: a case-control study
High-resolution computed tomography and health-related quality of life in Mycobacterium avium complex disease
Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections
Serodiagnosis of Mycobacterium avium complex and Mycobacterium abscessus complex pulmonary disease by use of IgA antibodies to glycopeptidolipid core antigen
Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM
Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans
Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease
Sero-diagnosis of Mycobacterium avium complex lung disease using serum immunoglobulin A antibody against glycopeptidolipid antigen in Taiwan
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study
Increasing Recovery of Nontuberculous Mycobacteria from Respiratory Specimens over a 10-Year Period in a Tertiary Referral Hospital in South Korea
Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus
Potential for use of the Seegene Anyplex MTB/NTM real-time detection assay in a regional reference laboratory
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia
Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry
Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains
Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients
A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study
Serodiagnosis of Mycobacterium avium complex disease in humans: translational research from basic mycobacteriology to clinical medicine
A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease
The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus
Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin
The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China
Increased Frequency of Nontuberculous Mycobacteria Detection at Potable Water Taps within the United States
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis
Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nontuberculous Mycobacteria from Clinical Isolates
Separation of Mycobacterium abscessus into subspecies or genotype level by direct application of peptide nucleic acid multi-probe- real-time PCR method into sputa samples
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection
Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012
Comparison of Mycobacterial Growth Indicator Tube with Culture on RGM Selective Agar for Detection of Mycobacteria in Sputum Samples from Patients with Cystic Fibrosis
Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area
Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates
In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease
Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study
Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK
Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry.
Psoas Abscess Due to Mycobacterium avium in A Patient with Chronic Lymphocytic Leukemia－Case Report and Review
In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates
Unilateral Lung Involvement of Nodular Bronchiectatic Mycobacterium Avium Complex Pulmonary Diseases: Proportion and Evolution on Serial CT Studies
Improved Clinical Outcome After Treatment of Mycobacterium abscessus Complex Pulmonary Disease in Children With Cystic Fibrosis
In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance
Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients
Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease
A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims.
Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015.
Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment
Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice
Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus.
Mycobacterium abscessus Soft Tissue Infection: Review of Published Cases and Challenges in Treatment.
Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis
Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease
Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.
Prevalence of depressive symptoms and related risk factors in Japanese patients with pulmonary nontuberculous mycobacteriosis.
Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity
Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes
Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study
Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus.
Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report
Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA)
Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study
Serum Krebs von den Lungen-6 level in the disease progression and treatment of Mycobacterium avium complex lung disease.
The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
Non-Tuberculous Mycobacteria in Respiratory Specimens of Patients with Obstructive Lung Diseases-Colonization or Disease?
Population pharmacokinetic evaluation and optimization of amikacin dosage regimens for the management of mycobacterial infections
Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles
Concomitant Presence of Aspergillus Species and Mycobacterium Species in the Respiratory Tract of Patients: Underestimated Co-occurrence?
Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease
Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches
An Intensified Regimen Containing Linezolid Could Improve Treatment Response in Mycobacterium abscessus Lung Disease
Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study
Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections
Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment
Non - tuberculous mycobacteriosis of the lungs - diagnostic possibilities in the practice of the pulmonologist
Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment
Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens.
Minimal Inhibitory Concentration of Clofazimine among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
A case of relapsed Mycobacterium chelonae pulmonary infection presenting with severe weight loss and treated with a combination of antibiotic therapy and percutaneous feeding
Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.
Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.
GenSeizer: a Multiplex PCR-Based Targeted Gene Sequencing Platform for Rapid and Accurate Identification of Major Mycobacterium Species.
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection.
Mycobacterium avium complex infection in a patient with systemic sclerosis- associated interstitial lung disease: A case report
Ex vivo infection of murine precision-cut lung tissue slices with Mycobacterium abscessus: a model to study antimycobacterial agents
Nontuberculous mycobacteria - clinical and laboratory diagnosis: experiences from a TB endemic country
Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease
European Respiratory Society International Congress, Madrid, 2019: nontuberculous mycobacterial pulmonary disease highlights
High-Resolution CT Findings as Predictive Factors for Recurrent Nontuberculous Mycobacterial Pulmonary Disease after Successful Treatment.
Application of acid-fast staining combined with GeneXpert MTB/RIF in the diagnosis of non-tuberculous mycobacteria pulmonary disease.
Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease.
Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.
PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population.
The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
Trends in the nontuberculous mycobacterial disease mortality rate in Japan: A nationwide observational study, 1997-2016
Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization.
Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study.
Non tuberculous mycobacteria pulmonary disease: patients and clinicians working together to improve the evidence base for care.
Outcomes of inhaled amikacin-containing multidrug regimens for Mycobacterium abscessus pulmonary disease.
Rapid macrolide and amikacin resistance testing for Mycobacterium abscessus in people with cystic fibrosis.
Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.
Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.
STING Receptor Agonists
Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.
Chronic Fatigue Syndrome
Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.
Spatio-Temporal Regulation of DNA Repair
DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.
Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.
Hereditary Sensory Autonomic Neuropathy
Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.
Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.
Neural Activity: Imaging
Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.
Applications of Molecular Barcoding
The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.